Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
3 reviews
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Avail. Save
422301 50 tests 68€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests 156€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature

Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  2. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  3. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  4. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  5. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  8. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  10. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  24. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  25. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  26. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  27. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  28. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  29. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  30. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  31. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  32. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  33. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  34. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  35. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  36. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  37. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  38. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  39. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  40. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  41. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  42. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  43. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  44. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  45. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  46. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  47. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  48. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  49. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  50. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  51. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  52. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  53. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  54. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  55. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  56. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  57. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  58. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  59. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  60. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  61. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  62. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  63. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  64. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  65. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  66. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  67. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  68. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  69. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  70. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  71. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  72. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  73. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  74. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  75. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  76. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  77. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  78. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
  79. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  80. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  81. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  82. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  83. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  84. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  85. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  86. Wright A, et al. 2017. J Allergy Clin Immunol. . 10.1016/j.jaci.2017.04.025. PubMed
  87. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  88. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
Publication Library

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07.14.2016

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Login / Register
Forgot your password? Reset password?
Create an Account